As of 2026-03-31, the Relative Valuation of Celldex Therapeutics Inc (CLDX) is (84.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.48 USD, the upside of Celldex Therapeutics Inc based on Relative Valuation is -385.1%.
The range of the Relative Valuation is (78.91) - (85.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.9x - 24.4x | 22.2x |
| Forward P/E multiples | 20.3x - 21.9x | 21.1x |
| Fair Price | (78.91) - (85.13) | (84.06) |
| Upside | -367.7% - -388.8% | -385.1% |
| Date | P/E |
| 2026-03-24 | -8.02 |
| 2026-03-23 | -8.18 |
| 2026-03-20 | -7.95 |
| 2026-03-19 | -7.73 |
| 2026-03-18 | -7.34 |
| 2026-03-17 | -7.63 |
| 2026-03-16 | -7.77 |
| 2026-03-13 | -7.59 |
| 2026-03-12 | -7.69 |
| 2026-03-11 | -8.03 |
| 2026-03-10 | -8.01 |
| 2026-03-09 | -7.91 |
| 2026-03-06 | -7.57 |
| 2026-03-05 | -7.55 |
| 2026-03-04 | -7.60 |
| 2026-03-03 | -7.45 |
| 2026-03-02 | -7.72 |
| 2026-02-27 | -7.74 |
| 2026-02-26 | -7.88 |
| 2026-02-25 | -7.93 |
| 2026-02-24 | -6.39 |
| 2026-02-23 | -6.26 |
| 2026-02-20 | -5.92 |
| 2026-02-19 | -6.06 |
| 2026-02-18 | -5.92 |
| 2026-02-17 | -5.90 |
| 2026-02-13 | -5.92 |
| 2026-02-12 | -6.06 |
| 2026-02-11 | -6.33 |
| 2026-02-10 | -6.34 |
| 2026-02-09 | -6.38 |
| 2026-02-06 | -6.11 |
| 2026-02-05 | -5.81 |
| 2026-02-04 | -6.24 |
| 2026-02-03 | -6.48 |
| 2026-02-02 | -6.34 |
| 2026-01-30 | -6.33 |
| 2026-01-29 | -6.35 |
| 2026-01-28 | -6.37 |
| 2026-01-27 | -6.75 |
| 2026-01-26 | -6.84 |
| 2026-01-23 | -6.67 |
| 2026-01-22 | -6.91 |
| 2026-01-21 | -6.73 |
| 2026-01-20 | -6.47 |
| 2026-01-16 | -6.60 |
| 2026-01-15 | -6.61 |
| 2026-01-14 | -6.78 |
| 2026-01-13 | -6.67 |
| 2026-01-12 | -6.60 |